Stocks 19 May 2026 - 23 May 2026

Caesars Stock Gains as Market Eyes Vegas Demand and Deal Chatter
····

Caesars Stock Gains as Market Eyes Vegas Demand and Deal Chatter

Caesars Entertainment shares closed at $28.47 Friday, up 2.04% on the day and about 2.4% for the week, ahead of a three-day U.S. market break for Memorial Day. The company reported first-quarter net revenue of $2.87 billion and a net loss of $98 million. Caesars outperformed gaming peers MGM Resorts, Las Vegas Sands, and DraftKings on Friday. Exclusive takeover talks with Tilman Fertitta reportedly continue.
May 23, 2026
Monarch Casino Shares Tick Higher With Holiday Looming, Legal Issue Still Present
····

Monarch Casino Shares Tick Higher With Holiday Looming, Legal Issue Still Present

Monarch Casino & Resort shares rose 0.6% to $116.91 Friday afternoon, as investors weighed record first-quarter results against a $78.5 million construction litigation liability. Net income jumped 38.9% to $27.6 million on revenue of $136.6 million. Monarch repurchased $17.6 million in shares and declared a 30-cent dividend. The move came ahead of the Memorial Day market closure.
May 22, 2026
Texas Instruments jumps after AI power chip push
····

Texas Instruments jumps after AI power chip push

Texas Instruments shares rose 5.7% to $315.34 by early afternoon Friday after Seaport Global upgraded the stock to Buy with a $400 target. The move followed strong first-quarter results and optimism over demand for TI’s power-management chips in AI data centers. The Philadelphia semiconductor index gained 2.4%. TI shares are up more than 80% since January.
May 22, 2026
Cass Stock Slips Before Dividend Date as Freight Data Teases a Recovery
····

Cass Stock Slips Before Dividend Date as Freight Data Teases a Recovery

Cass Information Systems shares fell 0.57% to $46.24 in light early trading Friday, with volume at 2,990 shares, well below average. The company declared a 32-cent quarterly dividend, payable June 15 to holders as of June 5. Cass’s April Transportation Index showed shipments down 4.4% year-on-year but up slightly from March. First-quarter net revenue rose 5.8% to $49.1 million; net income slipped 1.5% to $8.8 million.
May 22, 2026
HeartBeam Shares Hover Near $1 With Cash, Launch Timeline in Focus
····

HeartBeam Shares Hover Near $1 With Cash, Launch Timeline in Focus

HeartBeam Inc. shares rose 2% to $0.94 in premarket trading Friday, nearing $1 as investors weighed early sales efforts against ongoing funding risks. The company reported a $4.7 million Q1 net loss and $2 million in cash at March 31, later raising $11.5 million in April. HeartBeam expects no material revenue in 2026 and disclosed “substantial doubt” about its ability to continue operating. No new company news was released Friday.
May 22, 2026
Turtle Beach Rises as CFO Leaves, 2026 Outlook in Focus
····

Turtle Beach Rises as CFO Leaves, 2026 Outlook in Focus

Turtle Beach shares rose 3.83% to $11.12 Thursday after the company named Andrew Clipsham interim CFO, replacing Mark Weinswig, who resigns June 15. The company reaffirmed its 2026 outlook despite reporting a first-quarter net loss of $15.2 million on $42.2 million in revenue. Turtle Beach expects full-year 2026 net revenue of $335–$355 million and adjusted EBITDA of $44–$48 million.
May 22, 2026
Abivax Shares On the Move Again As Filing Catches Trader Interest Ahead of June
····

Abivax Shares On the Move Again As Filing Catches Trader Interest Ahead of June

Abivax SA’s Nasdaq-listed shares rose 3.5% to $124.03 Thursday as investors awaited late-Q2 topline data from its Phase 3 trial of obefazimod for ulcerative colitis. A May 20 SEC filing showed shareholders approved capital-raising mandates and a U.S. ATM program with 78.2% support. The company recently repurchased royalty certificates for $90 million, partly in ADSs. Paris shares closed at 105.10 euros, up 2.14%.
May 21, 2026
AYTU Stock Slips Before Exxua Update Investors Are Watching
····

AYTU Stock Slips Before Exxua Update Investors Are Watching

Aytu BioPharma shares fell 3% to $2.08 on Thursday after reporting a quarterly revenue drop to $12.4 million from $18.5 million a year earlier. Exxua, its new antidepressant, contributed $2.4 million, while legacy ADHD drug sales declined. The company will present at the Lytham Partners Spring 2026 Investor Conference on May 28. Cash and cash equivalents stood at $26.7 million at quarter-end.
May 21, 2026
WD-40 Down Ahead of Holiday Weekend
····

WD-40 Down Ahead of Holiday Weekend

WD-40 shares fell $2.71 to $205.30 late Thursday morning as consumer staples led S&P 500 sector losses and oil prices rose. The stock gave back part of Wednesday’s gain, trading about 1.3% below the prior close. WD-40 last reported higher quarterly sales and reaffirmed full-year guidance, but investors remain focused on cost and oil risks. Market value stood near $2.77 billion.
May 21, 2026
CEVA Stock Is Near a Breakout: The AI Licensing Signal Traders Are Watching
····

CEVA Stock Is Near a Breakout: The AI Licensing Signal Traders Are Watching

CEVA, Inc. shares hovered near a 52-week high in pre-market trading Thursday, last indicated at $37.98 after closing at $38.03. The chip-licensing firm reported first-quarter revenue up 11% to $27 million, but posted a net loss of $4.5 million. CEVA recently announced a Bluetooth licensing deal with a major U.S. chipmaker and said AI accounted for over 20% of its licensing revenue.
May 21, 2026
AMOD Stock Alert: Alpha Modus’ Android Launch Puts This Tiny Fintech Bet on the Clock
····

AMOD Stock Alert: Alpha Modus’ Android Launch Puts This Tiny Fintech Bet on the Clock

Alpha Modus Holdings’ Alpha Cash app launched on Android, completing rollout across iOS and Android platforms. AMOD shares closed at $0.20 Wednesday, down 5.09%, and traded at $0.21 premarket. The company reported $35,508 in cash and no revenue as of March 31, with a $4 million Q1 net loss. Alpha Cash targets underbanked users but faces competition from larger fintech firms.
May 21, 2026
Jaguar Health Shares Spike After 816% Revenue Jump, But Trial Results Still Key
····

Jaguar Health Shares Spike After 816% Revenue Jump, But Trial Results Still Key

Jaguar Health shares rose 9.2% to $3.67 Wednesday after first-quarter revenue jumped to $20.3 million, mainly from a U.S. licensing deal for Mytesi and Canalevia-CA1. Trading volume surged to 593,152 shares. Net loss narrowed to $7.0 million from $10.5 million a year earlier. The company’s crofelemer rare-disease trial advanced with its first pediatric patient entering an extension phase.
May 21, 2026
Akebia Shares Bounce 12% After Volatile Session
····

Akebia Shares Bounce 12% After Volatile Session

Akebia Therapeutics shares rose 12% to $1.01 in late trading Wednesday, rebounding from a two-day slide on heavy volume. The move followed first-quarter results showing Vafseo revenue climbed to $15.8 million while Auryxia sales fell to $36.2 million. Total revenue dropped to $53.5 million, with a net loss of $9.1 million. Investors weighed Vafseo’s growth against declining Auryxia sales and generic competition.
May 21, 2026
HeartCore Cash Concerns Leave HTCR Shares Flat
····

HeartCore Cash Concerns Leave HTCR Shares Flat

HeartCore Enterprises shares closed at $2.70 Wednesday, up 2 cents, with thin volume of 23,040 shares. The company reported a 40.5% drop in quarterly revenue and an 86.4% decline in gross profit. Its 10-Q cited “substantial doubt” about its ability to continue as a going concern, with $0.8 million in cash and a $15.6 million accumulated deficit at March 31. No new corporate announcements were posted.
May 20, 2026
Krispy Kreme Stock Pops as DNUT’s Turnaround Faces Its Next Test
·····

Krispy Kreme Stock Pops as DNUT’s Turnaround Faces Its Next Test

Krispy Kreme shares climbed 4.4% to $3.35 Wednesday, outpacing major indexes as McDonald’s traded flat. The company reported first-quarter net revenue of $367 million, down 2.2%, with a narrowed net loss of $22.7 million and adjusted EBITDA up 38% to $33.1 million. Krispy Kreme ended Q1 with 15,125 global points of access, down 15.9% from a year earlier. Recent promotions included free doughnuts for graduates and the return of a lemon-filled item.
May 20, 2026
Neogen insider activity points to tax transaction, not open market sell
····

Neogen insider activity points to tax transaction, not open market sell

Amy Rocklin, Neogen Corp.’s former chief legal officer, converted 35,183 restricted stock units into common shares and had 10,241 withheld for taxes after leaving the company, according to a U.S. securities filing. Rocklin held 82,182 shares following the May 18 transaction. The move comes as Neogen restructures and prepares to sell its global genomics business to Zoetis for $160 million.
May 20, 2026
Pilbara Minerals Slides as Lithium Rally Faces Supply Hurdle
····

Pilbara Minerals Slides as Lithium Rally Faces Supply Hurdle

PLS Group shares closed at A$5.92 Tuesday, down 1.33%, underperforming the S&P/ASX 200’s 1.17% gain. The stock remains nearly 9% below its May 12 high despite record March-quarter production. China lithium carbonate prices fell 2.61% on May 19 as producers restarted mining. Mineral Resources announced it will restart its Bald Hill lithium mine in July, adding about 370 jobs.
May 19, 2026
Rolls-Royce Stock Jumps Again as Traders Test the FTSE Comeback Bet
····

Rolls-Royce Stock Jumps Again as Traders Test the FTSE Comeback Bet

Rolls-Royce shares climbed 2.2% to 1,183.2 pence in early London trading Tuesday, outperforming the FTSE 100. The stock remained below its 52-week high as investors focused on recovering airline engine flying hours and upcoming share buybacks. UK payrolls fell by 100,000 in April and unemployment rose to 5.0%. Analyst consensus puts Rolls-Royce’s 2026 underlying EBIT at £4.13 billion.
May 19, 2026
1 2 3 4 … 9

Stock Market Today

  • Markets Brace Amid Middle East Tensions
    May 30, 2026, 9:40 AM EDT. Global markets are closely monitoring geopolitical developments in the Middle East for potential impacts on oil prices and broader financial stability. Investors exhibit caution ahead of possible escalations, seeking safe-haven assets amid uncertainty. The situation remains fluid, with market participants balancing risk exposure against expected volatility. Analysts advise vigilance, noting that any significant regional conflict could disrupt energy supplies and influence commodity markets. While current trading reflects a wait-and-see stance, the potential for rapid shifts persists, underscoring the importance of the Middle East in global economic dynamics.